Investor Relation Menu

• IR Home
• Corporate Info
  • Chairman's Statement
  • Values and Brand Promise
  • Board Of Directors
  • Key Management
• Our Business Units
• Financial Info
  • Financials
  • Annual Reports
  • Sustainability Report
• Newsroom
  • Announcements
  • Press Releases
• Stock Info
• Info Request
  • Email Alerts
  • IR Contact

News

Change - Announcement Of Resignation Of Non-Executive Director

BackMar 22, 2019

Announcement Title	Change - Announcement of Cessation
Date & Time of Broadcast	Mar 22, 2019 17:29
Status	New
Announcement Sub Title	RESIGNATION OF NON-EXECUTIVE DIRECTOR
Announcement Reference	SG190322OTHR56NT
Submitted By (Co./ Ind. Name)	Stanley Woo
Designation	Group Financial Controller
Description (Please provide a detailed description of the event in the box below)	This announcement has been prepared by the Company and reviewed by the Company's sponsor, Xandar Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement. Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) Address: 3 Shenton Way, #24-02 Shenton House, Singapore 068805 Telephone number: (65) 6319 4954
Additional Details
Name Of Person	Koh Boon How
Age	37
Is effective date of cessation known?	Yes
If yes, please provide the date	22/03/2019
Detailed Reason (s) for cessation	Mr Charles Wang will be the new representative director of Luye Medical Group Pte Ltd.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?	No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?	No
Any other relevant information to be provided to shareholders of the listed issuer?	No
Date of Appointment to current position	03/01/2019
Does the AC have a minimum of 3 members (taking into account this cessation)?	Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)	2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months	3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)	Non-Executive Director
Role and responsibilities	Please refer to the Job Title section above
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries	No
Shareholding interest in the listed issuer and its subsidiaries?	Yes
Shareholding Details	Direct interest of 1,500,000 ordinary shares in AsiaMedic Limited
Past (for the last 5 years)	Please refer to attachment
Present	Please refer to attachment

Attachments

1. Attachment 1 (Size: 2,673 bytes)